AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33896751 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial infusion chemotherapy plus microsphere embolization for gastroesophageal cancer and transarterial chemoembolization for hepatic metastasis
Number of subjects: 60
Study 33896751 — intervention group
Group type: COMPARATOR
Intervention: Transarterial infusion chemotherapy for gastroesophageal cancer and transarterial chemoembolization for hepatic metastasis
Number of subjects: 60
Study 33896751 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial infusion chemotherapy plus microsphere embolization
Number of subjects: 60
Study 36109083 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 472
Study 36109083 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 472
Study 33707990 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity program and individual-based counselling intervention
Number of subjects: 121
Study 33707990 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity program and group-based counselling intervention
Number of subjects: 121
Study 33707990 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 121
Study 33707990 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based intervention
Number of subjects: 121
Study 33707990 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-based intervention
Number of subjects: 121
Study 32543683 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 153
Study 32543683 — intervention group
Group type: COMPARATOR
Intervention: Blood Glucose Monitoring (BGM)
Number of subjects: 153
Study 32543683 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM
Number of subjects: 153
Study 32543683 — intervention group
Group type: COMPARATOR
Intervention: BGM
Number of subjects: 153
Study 35164836 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing training for GPs
Number of subjects: 0
Study 35164836 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 0
Study 34639295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chuna manual therapy (CMT) plus usual Korean traditional medicine care for three weeks (6-11 sessions)
Number of subjects: 132
Study 34639295 — intervention group
Group type: COMPARATOR
Intervention: Usual care including acupuncture, cupping, herbal medicine, moxibustion, and traditional physiotherapy
Number of subjects: 132
Study 34639295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chuna manual therapy (CMT) plus usual Korean traditional medicine care
Number of subjects: 132
Study 35304169 — intervention group
Group type: EXPERIMENTAL
Intervention: VIBeS Plus intervention delivered at home by psychologists and physiotherapists focusing on infant development and parental mental health.
Number of subjects: 120
Study 35304169 — intervention group
Group type: EXPERIMENTAL
Intervention: VIBeS Plus intervention for higher social risk families.
Number of subjects: 120
Study 35304169 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 120
Study 35304169 — intervention group
Group type: EXPERIMENTAL
Intervention: VIBeS Plus intervention.
Number of subjects: 120
Study 33167779 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning (ML) using support vector machines (SVM) and convolutional neural networks (CNN) trained on ventricular monophasic action potentials (MAPs) to predict sustained ventricular tachycardia/ventricular fibrillation (VT/VF) and mortality.
Number of subjects: 42
Study 33167779 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning (ML) using support vector machines (SVM) and convolutional neural networks (CNN) trained on ventricular monophasic action potentials (MAPs) to predict mortality.
Number of subjects: 42
Study 35561627 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal multisensory supportive interventions initiated 5 min before and during swaddled bathing.
Number of subjects: 48
Study 35561627 — intervention group
Group type: COMPARATOR
Intervention: Control group with mothers only present during bathing.
Number of subjects: 48
Study 34028202 — intervention group
Group type: EXPERIMENTAL
Intervention: Random sequence
Number of subjects: 0
Study 34028202 — intervention group
Group type: EXPERIMENTAL
Intervention: Random walk sequence
Number of subjects: 0
Study 36335918 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive strategy added to guideline-directed medical therapy
Number of subjects: 5179
Study 36335918 — intervention group
Group type: COMPARATOR
Intervention: Initial conservative strategy
Number of subjects: 5179
Study 33409923 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc, Vitamin A, and Magnesium supplementation (30 mg zinc gluconate capsule per day, 250 mg magnesium oxide tablet per day, 25,000 IU vitamin A capsule twice/week for 10 weeks)
Number of subjects: 86
Study 33409923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo capsules and tablets for 10 weeks)
Number of subjects: 86
Study 33324415 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water 4ml/kg orally three times a day
Number of subjects: 24
Study 36293881 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual-reality-based cognitive training (VRCT), 24 sessions, 100 min each, three days/week
Number of subjects: 99
Study 36293881 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (aerobic and resistance training), 24 sessions, 60 min each, two times/week for 12 weeks
Number of subjects: 99
Study 36293881 — intervention group
Group type: COMPARATOR
Intervention: Exercise intervention
Number of subjects: 99
Study 36293881 — intervention group
Group type: COMPARATOR
Intervention: VRCT
Number of subjects: 99
Study 36293881 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 99
Study 33758941 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated risk of iron overload
Number of subjects: 254
Study 33758941 — intervention group
Group type: COMPARATOR
Intervention: Typical risk of iron overload
Number of subjects: 254
Study 33758941 — intervention group
Group type: COMPARATOR
Intervention: Low iron status genotypes
Number of subjects: 254
Study 32829945 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Resistance (CR) exercise
Number of subjects: 66
Study 32829945 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Aerobic (CA) exercise
Number of subjects: 66
Study 32829945 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Resistance (CR) + Chronic Aerobic (CA) exercise
Number of subjects: 66
Study 35306161 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Infiltration Analgesia (LIA)
Number of subjects: 152
Study 35306161 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia Iliaca Compartment Block (FICB)
Number of subjects: 152
Study 35306161 — intervention group
Group type: COMPARATOR
Intervention: Spinal Anesthesia (Control Group)
Number of subjects: 152
Study 33819062 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose omega-3 fatty acids
Number of subjects: 0
Study 33819062 — intervention group
Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 0
Study 35049137 — intervention group
Group type: EXPERIMENTAL
Intervention: Early continuous blood purification (CBP)
Number of subjects: 130
Study 34648009 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (loading dose of 0.5 μg/kg over 15 minutes followed by a maintenance dose of 0.2 μg/kg per hour)
Number of subjects: 675
Study 34648009 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 675
Study 34648009 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion (normal saline)
Number of subjects: 675
Study 34648009 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 675
Study 35297655 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 441
Study 35297655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study 34527811 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 60
Study 34527811 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 60
Study 32511775 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic L. reuteri lozenges
Number of subjects: 447
Study 32511775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 447
Study 35268094 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-Chain Triglycerides (MCTs) - 2 g daily for two weeks
Number of subjects: 0
Study 35268094 — intervention group
Group type: COMPARATOR
Intervention: Canola oil (placebo control)
Number of subjects: 0
Study 34378693 — intervention group
Group type: EXPERIMENTAL
Intervention: SHAHRP program
Number of subjects: 348
Study 34378693 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 348
Study 33681130 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall detection device usage
Number of subjects: 336
Study 33681130 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall detection device features
Number of subjects: 336
Study 33681130 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of falls
Number of subjects: 336
Study 33681130 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of falls with instability
Number of subjects: 336
Study 35536382 — intervention group
Group type: EXPERIMENTAL
Intervention: Celery seed extract (1.34 g extract per day)
Number of subjects: 51
Study 35536382 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 51
Study 33410758 — intervention group
Group type: EXPERIMENTAL
Intervention: Be Prepared mHealth app
Number of subjects: 86
Study 33410758 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 86
Study 35077657 — intervention group
Group type: EXPERIMENTAL
Intervention: Háblame Bebé mobile application
Number of subjects: 37
Study 35077657 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 37
Study 34155075 — intervention group
Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH+) programme, which includes structured support and problem-solving for caregivers, delivered by a registered nurse through six 30-45 min telephone support sessions over 6 months.
Number of subjects: 925
Study 34155075 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 925
Study 34155075 — intervention group
Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH+) programme
Number of subjects: 925
Study 33147217 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry decontamination
Number of subjects: 0
Study 33147217 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet decontamination
Number of subjects: 0
Study 33147217 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined dry and wet decontamination
Number of subjects: 0
Study 33147217 — intervention group
Group type: COMPARATOR
Intervention: No decontamination (control)
Number of subjects: 0
Study 33147217 — intervention group
Group type: EXPERIMENTAL
Intervention: All decontamination protocols
Number of subjects: 0
Study 35723044 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-centered counseling
Number of subjects: 60
Study 35723044 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 33836690 — intervention group
Group type: EXPERIMENTAL
Intervention: Expedited delivery recommended in women with low CPR (open arm)
Number of subjects: 2160
Study 33836690 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care (concealed arm)
Number of subjects: 2160
Study 32950029 — intervention group
Group type: EXPERIMENTAL
Intervention: Duke score
Number of subjects: 260
Study 32950029 — intervention group
Group type: EXPERIMENTAL
Intervention: Apfel score
Number of subjects: 260
Study 32950029 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-smoking during pregnancy
Number of subjects: 260
Study 32950029 — intervention group
Group type: EXPERIMENTAL
Intervention: History of postoperative nausea/vomiting after cesarean delivery and/or morning sickness
Number of subjects: 260
Study 35301662 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 109
Study 35301662 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 109
Study 35301662 — intervention group
Group type: EXPERIMENTAL
Intervention: Rad_score
Number of subjects: 109
Study 32588036 — intervention group
Group type: EXPERIMENTAL
Intervention: XGBoost classifier
Number of subjects: 1407
Study 32588036 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) classifier
Number of subjects: 1407
Study 32843874 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical evidence technology (CET) - VisualDx; usage frequency not specified.
Number of subjects: 0
Study 36400394 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (Intervention group)
Number of subjects: 236
Study 36400394 — intervention group
Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (Control group)
Number of subjects: 236
Study 36400394 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (Intervention group) for cervical spine patients
Number of subjects: 236
Study 36400394 — intervention group
Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (Control group) for cervical spine patients
Number of subjects: 236
Study 32365242 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol/betamethasone dipropionate foam (Cal/BD foam)
Number of subjects: 36
Study 32365242 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol cream
Number of subjects: 36
Study 35110003 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) - single dose of aluminum gallium arsenide (GaAlAs) laser irradiation (808 nm; 350 milliwatts; 3.5 joule/point) with placebo medication.
Number of subjects: 54
Study 35110003 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol–caffeine tablets (3 times daily for the first couple of days after separator insertion, and as needed for the rest of the week) with placebo LED light.
Number of subjects: 54
Study 35110003 — intervention group
Group type: COMPARATOR
Intervention: Placebo procedures (control group).
Number of subjects: 54
Study 32476089 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Oral Exercise (SOE)
Number of subjects: 96
Study 32476089 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing Gum Exercise (GOE)
Number of subjects: 96
Study 32476089 — intervention group
Group type: EXPERIMENTAL
Intervention: SOE
Number of subjects: 96
Study 32476089 — intervention group
Group type: EXPERIMENTAL
Intervention: GOE
Number of subjects: 96
Study 32476089 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 34512931 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride injection combined with dexmedetomidine
Number of subjects: 93
Study 34512931 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone hydrochloride injection
Number of subjects: 93
Study 32213537 — intervention group
Group type: EXPERIMENTAL
Intervention: Anamorelin
Number of subjects: 40
Study 32213537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36206793 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic review kit intervention
Number of subjects: 7160421
Study 33401532 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric and eccentric exercises without external loads
Number of subjects: 17
Study 33401532 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercises without external loads (Control)
Number of subjects: 17
Study 33401532 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 17
Study 32351183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) treatment with a high level of CBD to low level of THC ratio
Number of subjects: 0
Study 32351183 — intervention group
Group type: COMPARATOR
Intervention: No pharmacological treatment
Number of subjects: 0
Study 34741653 — intervention group
Group type: EXPERIMENTAL
Intervention: Live online group resistance training
Number of subjects: 94
Study 34741653 — intervention group
Group type: COMPARATOR
Intervention: In-person group resistance training
Number of subjects: 94
Study 34118059 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/day vitamin D3
Number of subjects: 688
Study 34118059 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D3
Number of subjects: 688
Study 34118059 — intervention group
Group type: COMPARATOR
Intervention: ≥1000 IU/day vitamin D3 (pooled higher doses)
Number of subjects: 688
Study 34118059 — intervention group
Group type: COMPARATOR
Intervention: 200 IU/day (control)
Number of subjects: 688
Study 32316978 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous dendritic cell vaccines (DCV)
Number of subjects: 110
Study 32316978 — intervention group
Group type: COMPARATOR
Intervention: Autologous tumor cell vaccines (TCV)
Number of subjects: 110
Study 34080492 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Episodic Future Thinking (EFT)
Number of subjects: 160
Study 34080492 — intervention group
Group type: COMPARATOR
Intervention: Traditional Episodic Future Thinking (EFT)
Number of subjects: 160
Study 32771041 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle-frequency self-weighing (3-4 times/week) in the intervention arm
Number of subjects: 2607
Study 32771041 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency self-weighing (5-7 times/week) in the intervention arm
Number of subjects: 2607
Study 32771041 — intervention group
Group type: COMPARATOR
Intervention: High-frequency self-weighing (5-7 times/week) in the control arm
Number of subjects: 2607
Study 35314767 — intervention group
Group type: EXPERIMENTAL
Intervention: HGS-GLIM malnutrition
Number of subjects: 1359
Study 35314767 — intervention group
Group type: EXPERIMENTAL
Intervention: SMI-GLIM malnutrition
Number of subjects: 1359
Study 34848737 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 70
Study 34848737 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 70
Study 32069288 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitally enabled rehabilitation using devices (virtual reality video games, activity monitors, handheld computer devices) prescribed by a physiotherapist for 6 months in hospital and at home.
Number of subjects: 300
Study 32069288 — intervention group
Group type: COMPARATOR
Intervention: Control group received usual multidisciplinary inpatient and post-hospital rehabilitation care without additional digital devices.
Number of subjects: 300
Study 32069288 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary mobility outcomes and self-reported balance confidence and quality of life measures.
Number of subjects: 300
Study 32069288 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events in the intervention group.
Number of subjects: 300
Study 34644357 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical and cognitive training (PTCT)
Number of subjects: 314
Study 34644357 — intervention group
Group type: COMPARATOR
Intervention: Physical training (PT)
Number of subjects: 314
Study 32905968 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on roles and rights of HFCs
Number of subjects: 251
Study 32905968 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and information about HF performance using PBF indicators
Number of subjects: 251
Study 32905968 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous training of HFCs before the interventions
Number of subjects: 251
Study 36084360 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate Quality Index (CQI) improvement (3-point increment)
Number of subjects: 1476
Study 34393499 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 22
Study 34393499 — intervention group
Group type: EXPERIMENTAL
Intervention: Senna plus ispaghula husk
Number of subjects: 22
Study 35060398 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT) for postpartum depression delivered by public health nurses plus treatment as usual (TAU)
Number of subjects: 141
Study 35060398 — intervention group
Group type: COMPARATOR
Intervention: Control group (TAU alone)
Number of subjects: 141
Study 32668039 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week web-based distance education program
Number of subjects: 60
Study 32668039 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 35701773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamaldehyde mucoadhesive patches
Number of subjects: 0
Study 35701773 — intervention group
Group type: COMPARATOR
Intervention: Placebo mucoadhesive patches
Number of subjects: 0
Study 32184277 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 5
Study 32184277 — intervention group
Group type: COMPARATOR
Intervention: Placebo-containing aluminium adjuvant (AAHS)
Number of subjects: 5
Study 35896943 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine ER (200–600 mg/day)
Number of subjects: 374
Study 35896943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study 34286884 — intervention group
Group type: EXPERIMENTAL
Intervention: DUAL-TASK+AOT-MI group (action observation training–motor imagery)
Number of subjects: 25
Study 34286884 — intervention group
Group type: COMPARATOR
Intervention: DUAL-TASK group (dual-task training alone)
Number of subjects: 25
Study 34286884 — intervention group
Group type: EXPERIMENTAL
Intervention: DUAL-TASK+AOT-MI group
Number of subjects: 25
Study 34286884 — intervention group
Group type: COMPARATOR
Intervention: DUAL-TASK group
Number of subjects: 25
Study 32172522 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (one‐time oral dose of 120,000 IU)
Number of subjects: 35
Study 32172522 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8 mg of saccharide)
Number of subjects: 35
Study 33455975 — intervention group
Group type: EXPERIMENTAL
Intervention: Japan Diet (JD)
Number of subjects: 98
Study 33455975 — intervention group
Group type: COMPARATOR
Intervention: Partial Japan Diet (PJD)
Number of subjects: 98